Display Settings:

Format

Send to:

Choose Destination
    Clin Infect Dis. 2002 Apr 15;34(8):1137-42. Epub 2002 Mar 19.

    Abacavir hypersensitivity reaction.

    Source

    Departments of Medicine and Pharmacy Practice, State University of New York, Buffalo, NY, 14215, USA. rhewitt@buffalo.edu

    Abstract

    A hypersensitivity reaction occurs in association with initiation of abacavir therapy as part of combination antiretroviral therapy in approximately 3.7% of patients. The reaction is possibly the result of a combination of altered drug metabolism and immune dysfunction, which is poorly understood. White patients appear to be at higher risk and patients of African descent at lower risk of abacavir hypersensitivity. Clinical management involves supportive measures and discontinuation of abacavir therapy. Rechallenge with abacavir in a hypersensitive patient should be avoided because it might precipitate a life-threatening reaction.

    PMID:
    11915004
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk